Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in Chronic Heart Failure (VACHF)
NCT01156207Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jul 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Aliskiren Arm with Placebo Arm (2 arms). Primary endpoint: Left Ventricular Systolic Function (Global Longitudinal Strain) at 1 year. Status: unknown.
02
Drugs
aliskiren
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT01156207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156207.